SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-1 - General form for registration of securities under the Securities Act of 1933:
SEC Accession No. 0001213900-14-000604
Filing Date
2014-01-31
Accepted
2014-01-31 17:29:45
Documents
20

Document Format Files

Seq Description Document Type Size
1 REGISTRATION STATEMENT fs12014_actinium.htm S-1 2901135
2 CERTIFICATE OF AMENDMENT TO ARTICLES OF INCORPORATION FILED JANUARY 7, 2014.** fs12014ex3v_actinium.htm EX-3.5 1063
3 FORM OF COMMON STOCK WARRANT, DATED DECEMBER 27, 2013 AND JANUARY 10, 2014.** fs12014ex4viii_actinium.htm EX-4.8 117711
4 FORM OF LOCK-UP AGREEMENT, DATED DECEMBER 27, 2013.** fs12014ex4ix_actinium.htm EX-4.9 21144
5 ACTINIUM PHARMACEUTICALS, INC. AMENDED AND RESTATED 2013 STOCK PLAN.** fs12014ex10xxxiii_actinium.htm EX-10.33 275780
6 ACTINIUM PHARMACEUTICALS, INC. AMENDED AND RESTATED 2013 EQUITY INCENTIVE PLAN.* fs12014ex10xxxiv_actinium.htm EX-10.34 169555
7 FORM OF UNIT PURCHASE AGREEMENT, DATED DECEMBER 27, 2013 AND JANUARY 10, 2014.** fs12014ex10xxxv_actinium.htm EX-10.35 175724
8 FORM OF SUBSCRIPTION AGREEMENT, DATED DECEMBER 27, 2013 AND JANUARY 10, 2014.** fs12014ex10xxxvi_actinium.htm EX-10.36 183175
9 FORM OF REGISTRATION RIGHTS AGREEMENT, DATED DECEMBER 27, 2013 AND JANUARY 10, 2 fs12014ex10xxxvii_actinium.htm EX-10.37 173188
10 LETTER AGREEMENT, DATED SEPTEMBER 4, 2013, BETWEEN ACTINIUM PHARMACEUTICALS, INC fs12014ex10xxxviii_actinium.htm EX-10.38 1916
11 ACCOUNTANTS CONSENT fs12014ex23i_actinium.htm EX-23.1 4218
18 img001_v1.jpg GRAPHIC 138925
19 img003_v1.jpg GRAPHIC 142184
20 img002_v1.jpg GRAPHIC 177499
  Complete submission text file 0001213900-14-000604.txt   13390317

Data Files

Seq Description Document Type Size
12 XBRL fil-20130930.xml EX-101.INS 1657439
13 XBRL fil-20130930.xsd EX-101.SCH 88179
14 XBRL fil-20130930_cal.xml EX-101.CAL 46616
15 XBRL fil-20130930_def.xml EX-101.DEF 303662
16 XBRL fil-20130930_lab.xml EX-101.LAB 619077
17 XBRL fil-20130930_pre.xml EX-101.PRE 437791
Mailing Address 501 FIFTH AVENUE, 3RD FLOOR NEW YORK NY 10017
Business Address 501 FIFTH AVENUE, 3RD FLOOR NEW YORK NY 10017 212-300-2131
Actinium Pharmaceuticals, Inc. (Filer) CIK: 0001388320 (see all company filings)

IRS No.: 880378336 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-1 | Act: 33 | File No.: 333-193714 | Film No.: 14565833
SIC: 6770 Blank Checks